Skip to main content

Table 5 Time of presentation of leprosy reaction among UMDT/CT-BR patients according to type of reaction

From: Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil

 

At diagnosis

N (%)

In the 1st year after diagnosis

N (%)

Follow-up after 1st year

N (%)

Reaction-free

N (%)

Total

N (%)

RR

16 (22.5)

71 (34.6)

51 (35.9)

NA

138 (18.3)

ENL

0

9 (4.4)

32 (22.5)

NA

41 (5.4)

RR + Neu

6 (8.5)

15 (7.3)

7 (4.9)

NA

28 (3.7)

ENL + Neu

3 (4.2)

3 (1.5)

1 (0.7)

NA

7 (0.9)

Neuritis

43 (60.6)

77 (37.6)

29 (20.4)

NA

149 (19.8)

Others

3 (4.2)

30 (14.6)

22 (15.5)

NA

55 (7.3)

Total

71 (100)

205 (100)

142 (100)

335 (100)

753 (100)

  1. RR Reversal reaction, ENL Eritema Nodosum Leprosum, Neu neuritis, Others others manifestations